Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2010
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/22/2010US7741279 Modified pro-alpha chain of at least part of a secretory leukocyte protease inhibitor that is placed N-terminal to a triple helical forming domain of the pro-alpha chain; procollagen molecule; collagen matrix; treating chronic wounds and fibrotic disorders
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741116 Surgical device for skin therapy or testing
06/22/2010US7741078 Heparin-binding protein modified with heparan sulfate sugar chains, process for producing the same and pharmaceutical compositions containing the same
06/22/2010US7740854 Treatment of macrophage mediated disease
06/22/2010US7740842 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease
06/22/2010US7740834 Murine zcytor17 ligand polypeptides
06/22/2010US7740831 Compositions for potentiating glutathione
06/22/2010US7740830 Imaging, diagnosis and treatment of disease
06/22/2010CA2586538C Nitroxy steroids
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2479991C Process for production of crystals, crystals obtained thereby and their use in pharmaceutical preparations
06/22/2010CA2443633C Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
06/22/2010CA2389553C Heteroaryl-diazabicycloalkanes
06/22/2010CA2314818C Compositions of matter containing l-glutamine and pyridoxal-alpha-ketoglutarate
06/17/2010WO2010068520A2 Substituted imidazoheterocycle derivatives
06/17/2010WO2010067206A1 Lipid composition for the treatment of skin problems in companion animals
06/17/2010WO2010067036A1 Novel aryl c-xyloside compounds, and cosmetic use
06/17/2010WO2010066931A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
06/17/2010WO2010066914A2 Remedies for pemphigus containing anti fas ligand antibodies
06/17/2010WO2010066641A1 Oral composition
06/17/2010WO2010066100A1 The 2-oxo-1,3-oxaazocyclopentane-4-formamide derivatives and their uses as the immunosuppressant.
06/17/2010WO2009089380A3 Methods for p2ry5 mediated regulation of hair growth and mutants thereof
06/17/2010US20100152442 4-anilino quinazoline derivatives as antiproliferative agents
06/17/2010US20100152300 Stabilized compositions of alkylating agents and methods of using same
06/17/2010US20100152297 Composition for regulating cellular senescence comprising n-[2-(cyclohexy-loxyl)-4-nitrophenyl]-methanesulfonamide
06/17/2010US20100152293 Use of polyunsaturated ketones for the treatment of psoriasis
06/17/2010US20100152288 NOVEL a-LIPOIC ACID DERIVATIVES AND APPLICATIONS THEREOF
06/17/2010US20100152257 Antagonists of lysophosphatidic acid receptors
06/17/2010US20100152255 Organic Compounds
06/17/2010US20100152241 Inhibitors of store operated calcium release
06/17/2010US20100152238 Novel quinonoid derivatives of cannabinoids and their use in the treatment of malignancies
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152209 Compounds for Modulating TRPV3 Function
06/17/2010US20100152188 Novel Heterocyclic Compounds
06/17/2010US20100152180 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
06/17/2010US20100152178 Imidazole derivatives
06/17/2010US20100152176 Modulators of Muscarinic Receptors
06/17/2010US20100152169 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152148 Novel compounds
06/17/2010US20100152146 Topical Administration of Danazol
06/17/2010US20100152143 Methods of Treating Skin Disorders with Caffeic Acid Analogs
06/17/2010US20100152133 Use of chitosans to increase nail growth rate
06/17/2010US20100152095 Wound healing
06/17/2010US20100151060 Botanical butter stick lip balm
06/17/2010US20100151048 For therapy of psoriasis, eczema, ichthyosis, pruritus, dryness and dermatitis, which may cause skin to crack, chap or chafe
06/17/2010US20100151041 Hypersaturated gas in liquid
06/17/2010US20100151039 Skin moisturizing agent for oral intake and functional foods and drinks
06/17/2010US20100151008 Preparations and Methods for Textile and or Fiber Surface Finishing, Surface Finished Articles Prepared Thereby, and Uses Therefor
06/17/2010US20100151007 Compositions and methods for selective inhibition of vegf
06/17/2010US20100150994 Amphiphilic entity nanoparticles
06/17/2010US20100150977 Camomile treated glove
06/17/2010US20100150976 Biologically degradable multilayer system
06/17/2010US20100150975 Structured Composition Comprising an Encapsulated Active
06/17/2010US20100150900 Dry Powder Fibrin Sealant
06/17/2010US20100150896 Diaminoquinazoline inhibitors of dihydrofolate reductase
06/17/2010US20100150893 Methods of organ regeneration
06/17/2010US20100150879 Methods for the detection, isolation, and use of lipid phosphate phosphatase-3-positive stem cells
06/17/2010US20100150872 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2
06/17/2010US20100150869 Use of tellurium compounds for treatment of basal cell carcinoma and/or actinic keratosis
06/17/2010CA2746334A1 Remedies for pemphigus containing anti fas ligand antibodies
06/17/2010CA2746155A1 Oral composition
06/17/2010CA2745052A1 Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines
06/16/2010EP2196206A1 Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient
06/16/2010EP2196205A1 Topoisomerase poisons
06/16/2010EP2196202A1 Inflammation-inhibiting compounds Lys-Pro-Thr and Lys-Pro
06/16/2010EP2196195A2 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
06/16/2010EP2195039A1 Surgical hydrogel
06/16/2010EP2195032A2 Phase ii detoxification and antioxidant activity
06/16/2010EP2195030A1 Isoflavone formulation
06/16/2010EP2195000A2 Sprayable composition containing red vine leaf extract
06/16/2010EP2194782A1 Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell 1
06/16/2010EP1809271B1 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
06/16/2010EP1436281B1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/16/2010EP1244463B1 Agent which is anti-adhesive in relation to the pathogenic flora of the skin
06/16/2010CN1921873B Coriander oil and preparations which have antimicrobial and antiphlogistic effects and which contain said oil and use thereof
06/16/2010CN1921847B Amino alcohol compound
06/16/2010CN1917856B Oral moisture keeping agent for skin and functional food an drink
06/16/2010CN1903352B Medicine for treating beriberi
06/16/2010CN1867310B Composition and method for promoting hair growth
06/16/2010CN1681469B Orally administrable composition for improving hair and coat quality
06/16/2010CN1636550B Water-in-oil emulsion composition
06/16/2010CN1635864B Oligosaccharide aldonic acids and their topical use
06/16/2010CN1543338B Chitin microparticles and their medical uses
06/16/2010CN1517126B Drug compastion with thrombolysis, anti-inflammatory and cell protective function
06/16/2010CN101735970A Method for separating and purifying echinus symbiotic bacterial strains with a plurality of active functions
06/16/2010CN101735925A Health wine preventing computer radiate
06/16/2010CN101735305A Synthesizing method of L-carnosine
06/16/2010CN101732683A Chinese medicinal preparation for treating facial chloasma and preparation method thereof
06/16/2010CN101732681A Traditional Chinese medicine preparation used for treating fungal dermatopathy
06/16/2010CN101732678A Chinese medicinal powder for stopping bleeding, diminishing inflammation and promoting regeneration of mucosa
06/16/2010CN101732675A Chinese medicinal external tincture for treating alopecia areata
06/16/2010CN101732644A External preparation for treating gynaecopathia and dermatosis and preparation method thereof
06/16/2010CN101732642A Medicament for treating flat wart
06/16/2010CN101732640A External washing Chinese medicament for treating itchy skin
06/16/2010CN101732635A External Chinese medicament for treating dermatophytosis
06/16/2010CN101732632A Skin disease lotion composition and preparation method thereof